TIESHA GREGORY: Open Payments
NPI 1699169359 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,757 in 112 payments from 26 companies in 2025. Trend: 2023 $1,644 · 2024 $1,465 · 2025 $2,757
Food & beverage: $2,757
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $361 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $293 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $227 |
| Lilly USA, LLC | 4 | $206 |
| Exact Sciences Corporation | 9 | $187 |
| Novo Nordisk Inc | 7 | $185 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $140 |
| Novartis Pharmaceuticals Corporation | 5 | $137 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| GlaxoSmithKline, LLC. | 6 | $107 |
Products named: Kerendia, CAPLYTA, REXULTI, Cologuard Collection Kit, VRAYLAR, LEQVIO, TRELEGY ELLIPTA, ELIQUIS.
Industry payments across NY — which companies pay providers there.
